Cannabis Use Clinical Trial
— JOINTEFFORTOfficial title:
Joint Effort, a Mobile Prevention and Harm Reduction Application
The purpose of this study is to evaluate quantitatively and qualitatively a mobile application, Joint Effort, targeting safe cannabis use among consumers. This randomized controlled trial is currently conducted on the Joint Effort mobile application.
Status | Recruiting |
Enrollment | 800 |
Est. completion date | January 2025 |
Est. primary completion date | December 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria: - Aged between 18-35 years old - Be a non-medical cannabis user and have used in the last month - Understand, read and write French - Own a smartphone (iPhone) Exclusion Criteria: - None |
Country | Name | City | State |
---|---|---|---|
Canada | Université de Montréal | Montréal | Quebec |
Lead Sponsor | Collaborator |
---|---|
Centre hospitalier de l'Université de Montréal (CHUM) |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Protective Behavioral Strategies for Marijuana (PBSM-17) used | The French version of the questionnaire translated by Côté et al. (2021) will be used. The 17 items proposed in the scale, each representing a behavioral protection strategy, are measured in terms of frequency of use on a six-point Likert-type scale (never, rarely, occasionally, sometimes, often and always). As indicated by its developers, the total score of the PBSM-17 is obtained by calculating the total score of each item and then converting this raw score into a standardized form (T-score) ranging from 15 to 73. | 8 weeks | |
Secondary | Change in intention to take action on cannabis use | Intention is assessed by three items with a 7 points Likert Scale as recommended by Ajzen (2013): 1) "I intend to take action on my cannabis use within the next month" will be rated on a scale from 1 = strongly disagree to 7 = strongly agree; 2) "Over the next month, the chances of me taking action on my cannabis use are …" will be rated on a scale from 1=very low to 7=very high; 3) "Over the next month, I will be taking action on my cannabis use" will be rated on a scale from 1=very unlikely to 7=very likely. Intention items scores are tallied for an overall score (range of 3-21). | 8 weeks | |
Secondary | Cannabis use frequency | The frequency of cannabis use will be assessed using a question previously used in the Quebec (Canada) Survey on Cannabis (2022). | 8 weeks | |
Secondary | Severity of Dependence | Measured with the Severity of Dependence Scale (SDS) scale (Martin et al., 2006) which includes five items related to compulsive behaviors, concerns, anxiety, and feelings of loss of control in the context of cannabis use. Four of the items are scored on a Likert-type scale ranging from "never/almost never" (1) to "always" (4) and one item offers a scale ranging from "not difficult" (1) to "impossible" (4). Severity of dependance items scores are tallied for an overall score (range of 5-20). | 8 weeks | |
Secondary | Subjective engagement with the developed mobile application (acceptability) | Subjective engagement (self-reported) will be measured using the validated French version (Fontaine et al., 2020) of the User Engagement Scale - Short Form (UES-SF) (O'Brien et al., 2018). This 12-item instrument serves to measure four dimensions of engagement: 1) aesthetic appeal; 2) focused attention; 3) perceived usability, and 4) reward factor. Possible answers range from strongly disagree (+1) to strongly agree (+5). The possible total score ranges between 12 and 60. The score for each item will be interpreted and the scores for each dimension will be compared to indicate which are rated more highly than others. | 4 weeks | |
Secondary | Number of screens viewed in the mobile application | Objective data. This data will be collected automatically when users log into the application. | 8 weeks | |
Secondary | Total time of use of the mobile application | Objective data. This data will be collected automatically when users log into the application. | 8 weeks | |
Secondary | Number of days the mobile application was used | Objective data. This data will be collected automatically when users log into the application. | 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03253926 -
Effect of Lorcaserin on Cannabis Withdrawal and Self-administration
|
Phase 1/Phase 2 | |
Completed |
NCT04060602 -
Personalized Feedback Intervention to Reduce Risky Cannabis Use.
|
N/A | |
Completed |
NCT01212081 -
Assessment of Cannabis Craving in Schizophrenia Using Virtual Reality
|
||
Recruiting |
NCT04988490 -
Quantification of Cannabinoids and Comparison to Post-Surgical Pain Medication Requirements and Surgical Outcomes
|
||
Recruiting |
NCT05188404 -
Aging and Marijuana: Benefits, Effects, and Risks
|
||
Completed |
NCT03662737 -
VRT as a Biomarker of Cerebellar Dysfunction in Chronic Cannabis Use
|
||
Not yet recruiting |
NCT05999383 -
Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration
|
Phase 2 | |
Terminated |
NCT04436055 -
Intergenerational Effects of Paternal Periconceptional Cannabis and Other Drug Use (EPIC)
|
||
Active, not recruiting |
NCT04374773 -
Effects of Pregnancy-associated Hormones on THC Metabolism in Women
|
Phase 4 | |
Completed |
NCT04316741 -
Brief Intervention Combined With Health Coaching Via Social Media for Cannabis Use
|
N/A | |
Recruiting |
NCT05396638 -
Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder
|
N/A | |
Recruiting |
NCT05309226 -
Cannabis Use in Pregnancy and Downstream Effects on Maternal and Infant Health
|
||
Recruiting |
NCT03859089 -
Cannabis for Opioid Substitution Trial
|
||
Recruiting |
NCT05849636 -
Alerta Cannabis: Evaluation of Web-based Tailored Intervention
|
N/A | |
Enrolling by invitation |
NCT05521321 -
Feasibility and Acceptability of the Cannabis Awareness and Prevention Toolkit
|
N/A | |
Recruiting |
NCT05119244 -
Environment and Lung Cancer
|
N/A | |
Recruiting |
NCT04841655 -
Tobacco Cessation Among Smokers Under Alcohol and/or Cannabis Treatment
|
||
Terminated |
NCT04100590 -
Eye Tracking as a Biomarker of Cannabis Effects
|
Phase 2 | |
Completed |
NCT05167097 -
Mindsets and the Effectiveness of a Brief Intervention - Replication
|
N/A | |
Recruiting |
NCT04114903 -
Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity
|